Beta Bionics (BBNX) Capital Expenditures (2024 - 2026)

Beta Bionics has disclosed Capital Expenditures across 3 years of filings, most recently posting $1.0 million for Q2 2026.

• In Q2 2026, Capital Expenditures fell 41.6% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $5.6 million (up 23.07% YoY), while the FY2025 annual figure was $5.3 million, up 56.02% from the prior year.
• Capital Expenditures came in at $1.0 million for Q2 2026 at Beta Bionics, down from $1.4 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.9 million in Q4 2025 to a low of $333000.0 in Q1 2025.
• Average Capital Expenditures over 3 years is $1.1 million, with a median of $1.2 million recorded in 2025.
• The largest YoY upside for Capital Expenditures was 313.51% in 2026 against a maximum downside of 41.6% in 2026.
• Over 3 years, Capital Expenditures stood at $561000.0 in 2024, then soared by 239.22% to $1.9 million in 2025, then slumped by 45.4% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $1.0 million in Q2 2026, $1.4 million in Q1 2026, and $1.9 million in Q4 2025.